Dr. Venook is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 Divisadero St
San Francisco, CA 94143Phone+1 415-353-9888Fax+1 415-353-7150
Summary
- Dr. Alan Venook is a nationally renowned expert in colorectal and liver cancers at the UCSF Helen Diller Family Comprehensive Cancer Center where he leads the Gastrointestinal Oncology program. In his research, he focuses on treating liver tumors with directed approaches, including infusional chemotherapy and biological agents.
Venook earned a medical degree at UCSF in 1980. He spent two years in the Public Health Service following an internship in internal medicine at UCSF. He completed a residence in internal medicine at the University of California, Davis and a fellowship in hematology and oncology at UCSF. Venook, who has been on the medical staff at UCSF since 1988, is a professor of medicine in hematology and oncology.
Education & Training
- University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1985 - 1988
- University of California Davis HealthResidency, Internal Medicine, 1983 - 1985
- University of California San Francisco School of MedicineClass of 1980
Certifications & Licensure
- CA State Medical License 1981 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Join now to see all
Clinical Trials
- Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis Start of enrollment: 1998 Jun 01
- FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum Start of enrollment: 2003 Dec 01
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 477 citationsHepatobiliary cancers, Version 2.2021Al B. Benson, Michael I. D’Angelica, Daniel E. Abbott, Daniel A. Anaya, Robert A. Anders
Journal of the National Comprehensive Cancer Network. 2021-05-01 - 24 citationsPhase II Multicenter, Open-Label Study of Oral ENMD-2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma.Ghassan K. Abou-Alfa, Robert J. Mayer, Alan P. Venook, Allison F. O'Neill, Muhammad Shaalan Beg
The Oncologist. 2020-03-10 - 382 citationsCombined BRAF and MEK inhibition with dabrafenib and trametinib in BRAF V600-Mutant colorectal cancerRyan B. Corcoran, Chloe E. Atreya, Gerald Steven Falchook, Eunice L. Kwak, David P. Ryan
Journal of Clinical Oncology. 2015-09-21
Journal Articles
- Association of Coffee Intake with Survival in Patients with Advanced or Metastatic Colorectal CancerI-Wen Chang, Charles D Blanke, Alan P Venook, Richard M Goldberg, Jeffrey A Meyerhardt, Kimmie Ng, JAMA Oncology
- Identification of a Genomic Region Between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance)Hope S Rugo, Bryan P Schneider, Alan Venook, Clinical Cancer Research
Other
- Cabozantinib in Patients with Advanced and Progressing Hepatocellular CarcinomaAlan Venook, MD, The New England Journal of Medicine
https://www.doximity.com/articles/e0e95f3b-5b2a-480c-ab49-4608e3eb9632
UpToDate, Wolters Kluwer Health - 2013-03-12 - Nonsurgical local treatment strategies for colorectal cancer liver metastasesVenook AP
http://www.uptodate.com/contents/nonsurgical-local-treatment-strategies-for-colorectal-cancer-liver-
UpToDate, Wolters Kluwer Health - 2012-09-28
Press Mentions
- KRAS Inhibitors in Pancreatic Cancer: Hope on the Horizon?September 9th, 2024
- Clinical Controversy: Watch-and-Wait or Surgery in Rectal Cancer near Complete Responders?August 20th, 2024
- CRC in Middle Age Linked to Morning Sickness Pill from 60s, 70sMarch 19th, 2023
- Join now to see all
Grant Support
- Data Safety MonitoringNational Cancer Institute2007–2011
- C98-118-01: Sch58500 &Chemotherapy In Colorectal Cancer Metastatic To LiverNational Center For Research Resources2000–2002
- Core--Clinical Research Support ServicesNational Cancer Institute1999–2002
- Cancer And Leukemia Group BNational Cancer Institute1995–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: